Clinical Trial Research

Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation

Published in Mental Health Weekly Digest, September 1st, 2008

Addrenex Pharmaceuticals ( http://www.addrenex.com/ ) has made three strategic hires this month to further its goal of identifying and developing as many new drug candidates as possible over the next 18 months.

The fast-paced timeline they have set for drug discovery mirrors the company's recent successes in developing two new drugs, Clonicel(R) for attention deficit/hyperactivity disorder and CloniBID for hypertension, over the past two years. A new drug application has already been filed for CloniBID, with Food and Drug Administration review expected by December 2008, and Clonicel is in phase 3 clinical trials. Commercial rights to both drugs have been granted to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest

Source: Mental Health Weekly Digest (2008-09-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry